![Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses - Valentin - 2009 - Ultrasound in Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses - Valentin - 2009 - Ultrasound in](https://obgyn.onlinelibrary.wiley.com/cms/asset/69259540-9dce-4879-b8f9-3cec393dc4e9/mfig002.jpg)
Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses - Valentin - 2009 - Ultrasound in
![Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125 | Communications Biology Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125 | Communications Biology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs42003-020-01191-x/MediaObjects/42003_2020_1191_Fig1_HTML.png)
Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125 | Communications Biology
![CA-125: a marker for diagnosis and follow-up of pleuroperitoneal and lymph node tuberculosis | Annals of Saudi Medicine CA-125: a marker for diagnosis and follow-up of pleuroperitoneal and lymph node tuberculosis | Annals of Saudi Medicine](https://www.annsaudimed.net/cms/asset/8cf458fd-cc29-46e3-8fc1-8a5f74d85de3/asm-2-142f1.gif)
CA-125: a marker for diagnosis and follow-up of pleuroperitoneal and lymph node tuberculosis | Annals of Saudi Medicine
![HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6606092/MediaObjects/41416_2011_Article_BF6606092_Fig1_HTML.jpg)
HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer
![Cureus | Do Not Forget Poly (Adenosine Diphosphate-Ribose) Polymerase Inhibitors in Ovarian Carcinosarcoma Cureus | Do Not Forget Poly (Adenosine Diphosphate-Ribose) Polymerase Inhibitors in Ovarian Carcinosarcoma](https://assets.cureus.com/uploads/figure/file/382819/lightbox_b24d2fb0daed11ec95272bbfba8dd5ca-figure6-300.png)
Cureus | Do Not Forget Poly (Adenosine Diphosphate-Ribose) Polymerase Inhibitors in Ovarian Carcinosarcoma
![JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis | HTML JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis | HTML](https://www.mdpi.com/jcm/jcm-08-00607/article_deploy/html/images/jcm-08-00607-g001.png)
JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis | HTML
![Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13048-020-00681-0/MediaObjects/13048_2020_681_Fig4_HTML.png)
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text
![Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial - Annals of Oncology Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b36ed5bf-7780-4454-a65f-1708179ea117/gr1_lrg.jpg)
Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial - Annals of Oncology
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.va.gif)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction - The American Journal of Medicine CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction - The American Journal of Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9720b379-0149-46c9-99f8-095f98ce0e7c/gr1_lrg.jpg)
CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction - The American Journal of Medicine
![Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13048-020-00681-0/MediaObjects/13048_2020_681_Fig3_HTML.png)
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text
![Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review - Núñez - 2021 - European Journal of Heart Failure - Wiley Online Library Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review - Núñez - 2021 - European Journal of Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/94c62666-b223-4ae1-ab0e-8f092ea11211/ejhf2295-toc-0001-m.jpg)
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review - Núñez - 2021 - European Journal of Heart Failure - Wiley Online Library
![Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer - Gynecologic Oncology Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer - Gynecologic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8c9b1a64-1846-4378-af4d-9c28e2b88b52/fx1_lrg.jpg)
Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer - Gynecologic Oncology
![Table 1 from Level and evaluation of tumor marker CA-125 in ovarian cancer patients in Khyber Pakhtunkhwa, Pakistan. | Semantic Scholar Table 1 from Level and evaluation of tumor marker CA-125 in ovarian cancer patients in Khyber Pakhtunkhwa, Pakistan. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5d6f060039736a337655ff8c37f0605527be3327/2-Table1-1.png)